These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1825862)

  • 1. [Were the severe adverse effects on several organs and the marked blood pressure increase caused by oral contraceptives?].
    Bergbrant A; Mattsson LA; Kutti J
    Lakartidningen; 1991 Feb; 88(8):621-2. PubMed ID: 1825862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of parkinsonism induced by an oral contraceptive].
    Yasui M; Kihira T; Ota K; Funahashi K; Komai N
    No To Shinkei; 1992 Feb; 44(2):163-6. PubMed ID: 1567736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new ultra-low-dose combination oral contraceptive.
    Woutersz TB
    J Reprod Med; 1983 Jan; 28(1 Suppl):81-4. PubMed ID: 6403705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicentre study with a new biphasic oral contraceptive containing ethinylestradiol and desogestrel. Report on efficacy, cycle control and adverse experiences with special emphasis on blood pressure and weight.
    Dieben TO; van Beek A; Coelingh Bennink HJ
    Arzneimittelforschung; 1991 Sep; 41(9):996-8. PubMed ID: 1839126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience of a combined oral contraceptive with very low dose ethinyl estradiol.
    Akerlund M
    Acta Obstet Gynecol Scand Suppl; 1997; 164():63-5. PubMed ID: 9225641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptives and panic disorder.
    Deci PA; Lydiard RB; Santos AB; Arana GW
    J Clin Psychiatry; 1992 May; 53(5):163-5. PubMed ID: 1592843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oestrogen dose on whole blood platelet activation in women taking new low dose oral contraceptives.
    Norris LA; Bonnar J
    Thromb Haemost; 1994 Dec; 72(6):926-30. PubMed ID: 7740465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two monophasic oral contraceptives: gestodene/ethinyl estradiol versus desogestrel/ethinyl estradiol.
    Benagiano G
    Int J Fertil; 1989 Sep; 34 Suppl():31-9. PubMed ID: 2576255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oral contraception with low-dose progestagen].
    Heinzl S
    Med Monatsschr Pharm; 1989 Apr; 12(4):123-4. PubMed ID: 2657358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial of an oral contraceptive containing desogestrel and ethinyl estradiol.
    Weijers MJ
    Clin Ther; 1982; 4(5):359-66. PubMed ID: 6461412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of two oral contraceptives, containing 30 or 20 microg of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women.
    Ferreira AC; Montes MB; Franceschini SA; Toloi MR
    Int J Fertil Womens Med; 2001; 46(5):265-70. PubMed ID: 11720199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptives.
    Maclennan AH
    Curr Ther (Seaforth); 1987 Dec; 28(12):113-22. PubMed ID: 12317413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of combined low-dose oral contraceptives on blood viscosity and haematocrit.
    Ishak R; Loh Chooi Khim
    Malays J Reprod Health; 1991 Jun; 9(1):5-8. PubMed ID: 12317443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters.
    Winkler UH; Sudik R
    Contraception; 2009 Jan; 79(1):15-23. PubMed ID: 19041436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desogestrel, a new progestational compound, and the liver.
    Weijers MJ
    Arzneimittelforschung; 1983; 33(5):774-6. PubMed ID: 6223646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.